Over 25,000 Bottles of Blood Pressure Medication Recalled Due to Dissolution Issues

More than 25,000 bottles of 25-milligram chlorthalidone tablets, a prescription blood pressure medication manufactured by Inventia Healthcare Limited, have been recalled. The Class II recall, issued by the FDA, is due to the tablets failing dissolution specifications, which could affect how the active ingredient is absorbed and potentially impact the medication's effectiveness. The recall combines two separate actions from earlier this year and September.